Pineal-derived tripeptide for neuroprotection research.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) derived from pineal-gland peptide research, investigated for neuroprotective and antioxidant pathways.
Crosses the blood-brain barrier, modulates neuronal ROS production and apoptotic signaling under hypoxic stress.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Reviewed mechanisms by which short peptides like Pinealon regulate gene expression.
Identified DNA-binding and transcription-modulating activity for short peptides.
Pinealon administration during HHCY-induced developmental stress.
Reduced oxidative damage and improved offspring neurodevelopment markers.
Reviewed peptide bioregulator class including Pinealon as geroprotectors.
Documented reductions in mortality markers across long-term studies.
Lyophilized -20°C.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Pinealon is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
